Listening to the always highly professional $JNJ call 

Here's their not-for-profit vaccine timetable

Pushed their FY revenue/earnings numbers down but dividend (now on a 58th successive year of increases) keeps on growing...  Share called up 3% pre-market https://t.co/TWsT3aLocw